This P30 proposal is a request for for partial funding to support the operation of three core resource modules within the Tufts Center for Vision Research (TCVR). The modules are: 1) Morphology, 2) Monoclonal Antibodies and Tissue Resources, and 3) Computational Biology. An additional module associated with the TCVR, Transgenic Mice, is funded by the Institution. The TCVR currently comprises the research activities of 27 faculty members on the Tufts Health Sciences campus in Boston, including 17 NEI-funded Principal Investigators who hold a total of 22 NEI grants. Research activities of these investigators, who come from six different departments and two different schools of Tufts University, have been effectively integrated under the TCVR umbrella. This is facilitated by the close proximity of investigator labs within the urban campus environment of the Boston campus, by the cross-appointment of investigators to both clinical and basic science departments, and by their common service in the graduate programs. The modules are housed in research space located within three departments: Ophthalmology, Anatomy and Cellular Biology, and Neuroscience. Major scientific disciplines represented in the group include biochemistry, bioengineering, biostatistics, cell biology, developmental biology, epidemiology, genetics, immunology, molecular biology, neurobiology, nutrition, pharmacology, and physiology. The general categories of eye biology and disease addressed by these scientists include corneal physiology and disease, cataract, developmental biology of the eye, glaucoma, retinal disease, nutrition and aging in the eye, and ophthalmic genetics.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Center Core Grants (P30)
Project #
5P30EY013078-02
Application #
6518687
Study Section
Special Emphasis Panel (ZEY1-VSN (01))
Program Officer
Helmsen, Ralph J
Project Start
2001-05-01
Project End
2006-04-30
Budget Start
2002-05-01
Budget End
2003-04-30
Support Year
2
Fiscal Year
2002
Total Cost
$295,472
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02111
Chang, Jonathan S; Marra, Kyle; Flynn Jr, Harry W et al. (2016) Scleral Buckling in the Treatment of Retinal Detachment Due to Retinal Dialysis. Ophthalmic Surg Lasers Imaging Retina 47:336-40
Aziz, Hassan A; Flynn Jr, Harry W; Young, Ryan C et al. (2015) SYMPATHETIC OPHTHALMIA: Clinicopathologic Correlation in a Consecutive Case Series. Retina 35:1696-703
Diskin, Shiri; Chen, Wei-Sheng; Cao, Zhiyi et al. (2012) Galectin-8 promotes cytoskeletal rearrangement in trabecular meshwork cells through activation of Rho signaling. PLoS One 7:e44400
Saravanan, Chandrassegar; Cao, Zhiyi; Head, Steven R et al. (2009) Detection of differentially expressed wound-healing-related glycogenes in galectin-3-deficient mice. Invest Ophthalmol Vis Sci 50:5690-6
Gorczynska, I; Srinivasan, V J; Vuong, L N et al. (2009) Projection OCT fundus imaging for visualising outer retinal pathology in non-exudative age-related macular degeneration. Br J Ophthalmol 93:603-9
Diskin, Shiri; Cao, Zhiyi; Leffler, Hakon et al. (2009) The role of integrin glycosylation in galectin-8-mediated trabecular meshwork cell adhesion and spreading. Glycobiology 19:29-37
Saravanan, Chandrassegar; Liu, Fu-Tong; Gipson, Ilene K et al. (2009) Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin. J Cell Sci 122:3684-93
Manassakorn, Anita; Ishikawa, Hiroshi; Kim, Jong S et al. (2008) Comparison of optic disc margin identified by color disc photography and high-speed ultrahigh-resolution optical coherence tomography. Arch Ophthalmol 126:58-64
Uhlhorn, Stephen R; Borja, David; Manns, Fabrice et al. (2008) Refractive index measurement of the isolated crystalline lens using optical coherence tomography. Vision Res 48:2732-8
Brill, Elliott; Malanson, Katherine M; Radu, Roxana A et al. (2007) A novel form of transducin-dependent retinal degeneration: accelerated retinal degeneration in the absence of rod transducin. Invest Ophthalmol Vis Sci 48:5445-53

Showing the most recent 10 out of 82 publications